Skip to main content
logo
Mayne Pharma Group Limited (ASX:MYX)
Australia flag Australia · Delayed Price · Currency is AUD
2.915
+0.075 (2.64%)
Feb 11, 2026, 10:59 AM AEST

Mayne Pharma Group Revenue

In the fiscal year ending June 30, 2025, Mayne Pharma Group had annual revenue of 408.10M AUD with 5.07% growth. Mayne Pharma Group had revenue of 195.04M in the half year ending June 30, 2025.

Revenue
408.10M
Revenue Growth
+5.07%
P/S Ratio
0.57
Revenue / Employee
831.15K
Employees
491
Market Cap
230.74M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 2025408.10M19.70M5.07%
Jun 30, 2024388.40M204.81M111.56%
Jun 30, 2023183.59M26.44M16.82%
Jun 30, 2022157.15M-243.63M-60.79%
Jun 30, 2021400.78M-56.20M-12.30%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
CSL Limited23.73B
Sonic Healthcare9.65B
Cochlear2.34B
Monash IVF Group271.92M
Pro Medicus212.98M
Aroa Biosurgery79.26M
Lumos Diagnostics Holdings18.91M
Orthocell7.55M
Revenue Rankings

Mayne Pharma Group News

More News